Capital International Investors’s Sana Biotechnology SANA Stock Holding History

Capital International Investors’s Portfolio SANA Stock Details SANA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-430,000	Closed	-$701K	–	463
2024 Q4	$701K	Hold	430,000	–	–	﹤0.01%	442
2024 Q3	$1.79M	Sell	430,000 -2,071	-0.5%	-$10.9K	﹤0.01%	414
2024 Q2	$2.36M	Hold	432,071	–	–	﹤0.01%	422
2024 Q1	$4.32M	Hold	432,071	–	–	﹤0.01%	410
2023 Q4	$1.76M	Hold	432,071	–	–	﹤0.01%	424
2023 Q3	$1.67M	Sell	432,071 -179,600	-29%	-$965K	﹤0.01%	424
2023 Q2	$3.65M	Hold	611,671	–	–	﹤0.01%	416
2023 Q1	$2M	Hold	611,671	–	–	﹤0.01%	423
2022 Q4	$2.42M	Hold	611,671	–	–	﹤0.01%	410
2022 Q3	$3.67M	Buy	611,671 +432,071	+241%	+$3.12M	﹤0.01%	416
2022 Q2	$1.16M	Sell	179,600 -1,019,705	-85%	-$6.5M	﹤0.01%	429
2022 Q1	$9.91M	Sell	1,199,305 -695	-0.1%	-$5.62K	﹤0.01%	421
2021 Q4	$18.6M	Hold	1,200,000	–	–	﹤0.01%	408
2021 Q3	$27M	Hold	1,200,000	–	–	0.01%	390
2021 Q2	$23.6M	Hold	1,200,000	–	–	0.01%	400
2021 Q1	$40.2M	Buy	+1,200,000	New	+$39.1M	0.01%	356

Other funds holding SANA

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Canada Pension Plan Investment Board Toronto Ontario, Ontario, Canada $155B AUM 29.93% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capital International Investors's SANA Position: Q1 2025 in Review

Capital International Investors sold out of Sana Biotechnology (SANA) in Q1 2025, closing a stake of 430,000 shares — an estimated $701K sold.

Capital International Investors first reported a position in SANA in Q1 2021 and held it in 16 quarters. The position peaked at $40.2M in Q1 2021. 161 funds tracked by Wall St. Rank hold SANA as of Q1 2025.

Capital International Investors reported no remaining Sana Biotechnology position as of Q1 2025 after selling out during the quarter.
Capital International Investors sold 430,000 Sana Biotechnology shares in Q1 2025, an estimated $701K.
Capital International Investors first reported a position in Sana Biotechnology in Q1 2021 and held it in 16 quarters.
Capital International Investors's Sana Biotechnology position peaked at $40.2M in Q1 2021.
161 funds tracked by Wall St. Rank held Sana Biotechnology as of Q1 2025.

Based on Capital International Investors's 13F filing for Q1 2025, filed 12 May 2025.